Blog

The latest thoughts from Medicines Law & Policy partners.

Something is going terribly wrong with the EU Compulsory Licensing Regulation

This week the European Parliament will vote on amendments to the Commission’s proposed regulation of the European Parliament and the Council on compulsory licensing...

The Urgency of Compulsory Licensing Provision for Transfer of Technology in the Pandemic Treaty:...

Guest blog by Ronald Eberhard The Intergovernmental Negotiating Body, established by the World Health Assembly, aims to draft a global pandemic prevention, preparedness, and response...

Wrapping up 2023 with some noteworthy medicines, law and policy developments

Welcome to our 2023 end-of-the-year blog, our annual and highly-biased run-through of notable access to medicines events of the year that is about to...

TRIPS, technology transfer and access to pandemic countermeasures: What the WHO  Pandemic Treaty must...

The scrambling for access to Covid-19 vaccines by developing countries has reignited the debate on the WTO Trade-Related Aspects of Intellectual Property Rights (TRIPS)...

Medicines Law & Policy’s director, Ellen ’t Hoen, receives high Netherlands honour for her...

Ellen 't Hoen has been appointed Officer of the Order of Oranje-Nassau, a royal award which recognises those who merit particular appreciation from society...

The Power of TRIPS Flexibilities in Medicines Procurement

The government of Malaysia has began to roll out treatment of people infected with the hepatitis C virus (HCV).  Treatment will be a combination of...

WHO Fair Pricing Forum: Watching for Drug Industry Accountability

by Katrina Perehudoff and Jennifer Sellin Expensive medicines are a ubiquitous challenge from which no government is immune. Excessive price hikes are an urgent human...

Urgent collective action to meet the challenge of this pandemic crisis: a coronavirus related...

The Director-General of the World Health Organization (WHO), Tedros Adhanom Ghebreyesus, first described the present coronavirus (COVID-19) outbreak as a pandemic on the 11th...

Uganda tells ARIPO: No more patents for pharmaceuticals

Uganda has notified the African Regional Intellectual Property Organisation (ARIPO) that pharmaceutical inventions are not eligible for patentability in the country, Managing IP reported. With...

The People vs. AbbVie

Today, 9 May 2025, is an important day in court for the Dutch Pharmaceutical Accountability Foundation (PAF). In February 2023, PAF started a court...